Evaluation and comparison of the effects of injectable platelet-rich fibrin (i-PRF) and micro-osteoperforation (MOP) on accelerated orthodontic tooth movement. A split-mouth prospective randomized controlled trial.

KUSHAL TAORI0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1. Patients age varying from 15 â?? 30 years having class 2 division 1 and bimaxillary
•protrusion that requires removal of both maxillary first premolars.
•2. Patients with average growth pattern.
•3. Patients with no systemic conditions and diseases.
•4. Patients with fully erupted maxillary canine.
•5. Patients with healthy periodontal parameters having no clinical attachment loss or PPD
•more than 2-3 mm.
•6. Patients indicated for fixed orthodontic therapy.

•1. Patients with horizontal and vertical growth pattern.
•2. Patients with developmental and congenital syndromes.
•3. Patients with any systemic diseases like clotting disorders and conditions like pregnancy,
•anticoagulant therapy.
•4. Patients above the age of 30 years.
•5. Patients with deleterious habits like smoking are the subjects to be excluded.
•6. Patients undergoing removal or myofunctional orthodontic treatment.
•7. Patients on medication that decease orthodontic tooth movement like NSAIDS(Ibuprofen,
•aspirin, aceclofenac, diclofenac), bisphosphonates, hormonal replacement therapies.

发起方

KUSHAL TAORI